RxDoctor Payments Data

Shinil Shah, DO

Surgery · Houston, TXNPI 1861747677

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $8,547 of the $14,184 with a category attached, or 60.3%. It is spread thinly across 26 manufacturers, the largest accounting for just 23.9%.

$14,184in general payments, 2019–2025

Across 138 payments — averaging $102.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • W. L. Gore & Associates, Inc.$3K
  • Intuitive Surgical$3K
  • Activ Surgical, Inc.$1K
  • Baxter Healthcare$878
  • Medtronic$815
  • AbbVie$650
  • plus $4K from 20 others
$100,000in research payments, 2019–2025

Across 2 payments — averaging $50,000 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Activ Surgical, Inc.$75K
  • Intuitive Surgical Operations, Inc.$25K

What the payments were for

  • Consulting fees$1,1268%
  • Travel & lodging$4,51232%
  • Food & beverage$8,54760%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,184 in reported general payments places this provider in the 80th percentile of 1,830 surgery providers in Texas.

See all surgery providers in Texas →

Medicare billing

Part B allowed, 2024
$60,240
Medicare patients
139
Services billed
310

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Sucralfate21$4,085
Ursodiol17$852
Pantoprazole Sodium43$411
Ondansetron Hcl18$162
Dicyclomine Hcl11$156
Metoclopramide Hcl12$101
Methocarbamol23$94
Oxycodone Hcl24$69
Tramadol Hcl23$28
Omeprazole11$26

Paid to pharmacies, not to this prescriber.

Other surgery in Houston

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →